NEPHROS, INC. Disposal Group, Including Discontinued Operation, General and Administrative Expense
NEPHROS, INC. (NEPH) reported Disposal Group, Including Discontinued Operation, General and Administrative Expense of $535.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense · last filed 2024-03-15
- NEPHROS, INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2022-12-31 was $18.00K, a 87.41% decline year-over-year.
- NEPHROS, INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2022-09-30 was $161.00K, a 7.47% decline year-over-year.
- NEPHROS, INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2022-06-30 was $185.00K.
- NEPHROS, INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2022-03-31 was $171.00K.
- NEPHROS, INC. disposal group, including discontinued operation, general and administrative expense for fiscal 2022 was $535.00K, a 3.88% increase from fiscal 2021.
- NEPHROS, INC. disposal group, including discontinued operation, general and administrative expense for fiscal 2021 was $515.00K.
| Period end | Disposal Group, Including Discontinued Operation, General and Administrative Expense 3 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 6 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 9 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2022-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $179.00K derived: sum of 2 quarters · filed 2024-03-15 | $364.00K derived: sum of 3 quarters · filed 2024-03-15 | $535.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $161.00K 10-Q · filed 2023-11-08 | $346.00K derived: sum of 2 quarters · filed 2023-11-08 | $517.00K 10-Q · filed 2023-11-08 | $660.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $185.00K 10-Q · filed 2023-08-09 | $356.00K 10-Q · filed 2023-08-09 | $499.00K derived: sum of 3 quarters · filed 2023-08-09 | $673.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $171.00K 10-Q · filed 2023-05-10 | $314.00K derived: sum of 2 quarters · filed 2023-05-10 | $488.00K derived: sum of 3 quarters · filed 2023-05-10 | |
| 2021-12-31 | $143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $317.00K derived: sum of 2 quarters · filed 2023-03-23 | $515.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $174.00K 10-Q · filed 2022-11-15 | $372.00K 10-Q · filed 2022-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |